title: [FEATURES OF TREATMENT OF EOSINOPHILIC ESOPHAGITIS IN SCHOOLCHILDREN].
abstract: The inclusion of probiotic L. reuteri into the complex therapy of eosinophilic esophagitis significantly affect the outcomes of children--there was significant decrease in the number of eosinophils in the esophageal mucosa of children.
authors.forename: M I
authors.initials: MI
authors.lastname: Horodylovska
mesh_terms: D000293:Adolescent; D017332:Cetirizine / Q000627:therapeutic use; D002648:Child; D004032:Diet / Q000379:methods*; D057765:Eosinophilic Esophagitis / Q000178:diet therapy* / Q000188:drug therapy / Q000503:physiopathology; D004804:Eosinophils / Q000187:drug effects* / Q000473:pathology; D005260:Female; D039563:Histamine H1 Antagonists, Non-Sedating / Q000627:therapeutic use; D006801:Humans; D052200:Limosilactobacillus reuteri / Q000502:physiology*; D007958:Leukocyte Count; D008297:Male; D009092:Mucous Membrane / Q000187:drug effects / Q000473:pathology; D019936:Probiotics / Q000627:therapeutic use*
chemical_list: D039563:Histamine H1 Antagonists, Non-Sedating; C472067:levocetirizine; D017332:Cetirizine